Mechanism of transcriptional activation of the immediate early gene Egr-1 in response to PIXY321.

作者: RC Mignacca , HJ Lee , EM Kwon , KM Sakamoto

DOI: 10.1182/BLOOD.V88.3.848.848

关键词:

摘要: Studies with the granulocyte-macrophage colony-stimulating factor (GM- CSF)/interleukin-3 (IL-3) fusion protein, PIXY321, demonstrated enhanced biological activity of this molecule in comparison GM-CSF or IL-3 alone combination. Experiments were performed to study mechanisms resulting PIXY321-induced egr-1 expression human myeloid leukemic cells (TF-1). Transfections promoter constructs revealed that PIXY321 stimulation resulted fourfold induction -116 and -600 nucleotide (nt) constructs. We transfected a nt construct containing deletion cyclic AMP response element (CRE) mutation serum (SRE) both SRE CRE are necessary for maximal induction. However, 2.5-fold SRE-CRE-containing (P < .05), suggesting sufficient responsiveness. Electrophoretic mobility shift assays (EMSA) binding protein (CREB) was phosphorylated on serine 133 PIXY321-stimulated but not - unstimulated extracts from cultured GM-CSF. By Western analysis EMSA, CREB constitutively TF-1 grown before growth starvation. starvation, phosphorylation observed 10 minutes after stimulation. Further-more, ENSAs -unstimulated presence specific proteins recognize SRE. Our data demonstrate transcriptional regulation by is mediated

参考文章(19)
Nadia Rosenthal, [72] Identification of regulatory elements of cloned genes with functional assays Methods in Enzymology. ,vol. 152, pp. 704- 720 ,(1987) , 10.1016/0076-6879(87)52075-4
Heinrich H Gerhartz, Marianne Engelhard, Peter Meusers, Gunter Brittinger, W and Wilmanns, Gunther Schlimok, Peter Mueller, Dieter Huhn, Reinhard Musch, Wolfgang Siegert, Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas [see comments] Blood. ,vol. 82, pp. 2329- 2339 ,(1993) , 10.1182/BLOOD.V82.8.2329.2329
D. Ginty, J. Kornhauser, M. Thompson, H Bading, K. Mayo, J. Takahashi, M. Greenberg, Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and a circadian clock Science. ,vol. 260, pp. 238- 241 ,(1993) , 10.1126/SCIENCE.8097062
Arnold Ganser, Albrecht Lindemann, Gernot Seipelt, Oliver G. Ottmann, Friedhelm Herrmann, Matthias Eder, Jürgen Frisch, Gregor Schulz, Roland Mertelsmann, Dieter Hoelzer, Clinical effects of recombinant human interleukin-3. American Journal of Clinical Oncology. ,vol. 14, ,(1991) , 10.1097/00000421-199112001-00010
Michael Karin, Tod Smeal, Control of transcription factors by signal transduction pathways: the beginning of the end. Trends in Biochemical Sciences. ,vol. 17, pp. 418- 422 ,(1992) , 10.1016/0968-0004(92)90012-X
Richard Treisman, The serum response element. Trends in Biochemical Sciences. ,vol. 17, pp. 423- 426 ,(1992) , 10.1016/0968-0004(92)90013-Y
B. M. Curtis, D. E. Williams, H. E. Broxmeyer, J. Dunn, T. Farrah, E. Jeffery, W. Clevenger, P. deRoos, U. Martin, D. Friend, Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 88, pp. 5809- 5813 ,(1991) , 10.1073/PNAS.88.13.5809
K M Sakamoto, J K Fraser, H J Lee, E Lehman, J C Gasson, Granulocyte-macrophage colony-stimulating factor and interleukin-3 signaling pathways converge on the CREB-binding site in the human egr-1 promoter. Molecular and Cellular Biology. ,vol. 14, pp. 5975- 5985 ,(1994) , 10.1128/MCB.14.9.5975